🇺🇸 FDA
Patent

US 11492617

Compositions and methods for modulation of protein aggregation

granted A61PA61P25/00A61P25/28

Quick answer

US patent 11492617 (Compositions and methods for modulation of protein aggregation) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P25/00, A61P25/28